What is the prevalence of Anal Cancer?

Anal cancer is a relatively rare malignancy, with an estimated annual incidence of approximately 1 to 2 cases per 100,000 individuals in the United States and Europe. While not considered "ultra-rare," anal cancer accounts for a small percentage of all digestive tract cancers, and its true prevalence may be higher than recorded due to variations in screening and diagnostic reporting.

How common is anal cancer?

In the United States, the American Cancer Society estimates roughly 9,760 new cases of anal cancer are diagnosed annually. Because many cases are caught early and treated effectively, the number of people living with a history of the disease is significant, though precise global prevalence data remains limited. It is important to note that anal cancer is distinct from colorectal cancer, and clinical data suggests that incidence rates have been rising over the past few decades.

Who is most at risk for anal cancer?

Anal cancer does not affect all populations equally. Epidemiological data indicates several key trends in distribution:

• Gender Distribution: Anal cancer is more common in women than in men, though the incidence in men—particularly those who are immunocompromised or have specific viral exposures—has been increasing.


• Age of Onset: This condition is primarily diagnosed in adults, with the average age of diagnosis typically occurring between 60 and 65 years. It is extremely rare in pediatric populations.


• Geographic and Ethnic Variation: While globally distributed, higher rates are observed in developed nations. Certain high-risk groups, including individuals living with HIV, show a significantly higher incidence of anal cancer compared to the general population.

Why is prevalence data sometimes difficult to determine?

Accurate tracking of anal cancer is often hindered by underdiagnosis and the stigma associated with the disease, which can lead to delayed medical consultation. At DiseaseMaps.org, we have 8 community members currently sharing their experiences with anal cancer; these real-world accounts provide vital, non-clinical insights that complement formal epidemiological statistics and help bridge the gap in our understanding of the patient journey.

Next steps

• Consult a gastroenterologist or oncologist if you notice persistent symptoms like rectal bleeding, pain, or a mass in the anal area.


• Speak with your primary care provider about screening if you fall into a high-risk category.


• Join the anal cancer community on DiseaseMaps.org to connect with others and share experiences.


• Review clinical trial databases to stay informed about the latest research and treatment advancements.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• American Cancer Society (cancer.org) – Key Statistics for Anal Cancer


• National Cancer Institute (cancer.gov) – Anal Cancer Treatment (PDQ®)


• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet – Rare disease database and portal